Your browser doesn't support javascript.
loading
Chromosome 11q loss and MYCN amplification demonstrate synthetic lethality with checkpoint kinase 1 inhibition in neuroblastoma.
Keller, Kaylee M; Eleveld, Thomas F; Schild, Linda; van den Handel, Kim; van den Boogaard, Marlinde; Amo-Addae, Vicky; Eising, Selma; Ober, Kimberley; Koopmans, Bianca; Looijenga, Leendert; Tytgat, Godelieve A M; Ylstra, Bauke; Molenaar, Jan J; Dolman, M Emmy M; van Hooff, Sander R.
Afiliação
  • Keller KM; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • Eleveld TF; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • Schild L; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • van den Handel K; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • van den Boogaard M; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • Amo-Addae V; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • Eising S; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • Ober K; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • Koopmans B; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • Looijenga L; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • Tytgat GAM; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • Ylstra B; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit, Amsterdam, Netherlands.
  • Molenaar JJ; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • Dolman MEM; Department of Pharmaceutical Sciences, University Utrecht, Utrecht, Netherlands.
  • van Hooff SR; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
Front Oncol ; 12: 929123, 2022.
Article em En | MEDLINE | ID: mdl-36237330

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article